Scintigraphy with the labelled peptide ligand 99mTc-bombesin/GRP has been shown to detect prostate cancer and invasion of pelvic lymph nodes and should be applicable to other endocrine tumours particularly SCLC (De Vincentis et al, 2004). The gene discussed is GRP; the disease is prostate carcinoma.